Interestingly, in SODG93A ALS mouse model, immunomodulatory treatment increased the CD169+ cells that correlated with the enhancement of motor neuron survival, suggesting that monocyte invasion at least in this experimental model, acted as a neuroprotective in the early stage studied. The gene discussed is SIGLEC1; the disease is amyotrophic lateral sclerosis.